BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Abraxis BioScience, Inc. (Acquired by Celgene Corporation) 

Press releases archived for reference only.
11755 Wilshire Boulevard, 20th Floor
Los Angeles  California  90025  U.S.A.
Phone: Fax:


SEARCH JOBS





Segment
Pharmaceuticals





 Company News
Ex-Abraxis BioScience, Inc. Cancer Researcher-Turned-Billionaire Starts New Company 1/29/2013 8:10:14 AM
Celgene (Summit, New Jersey) (CELG) Completes Acquisition of Abraxis BioScience, Inc. 10/15/2010 11:03:55 AM
Celgene Corporation (CELG) and Abraxis BioScience, Inc. Announce Shareholder Vote in Favor of Merger 10/14/2010 7:57:35 AM
Antitope Announces EpiScreen Collaboration with Abraxis BioScience, Inc. 9/29/2010 1:27:33 PM
Celgene Corporation (CELG)/Abraxis BioScience, Inc. Receive Verbal Confirmation of Early Termination of Hart-Scott-Rodino (HSR) 30-Day Waiting Period 8/4/2010 9:52:00 AM
Abraxis BioScience, Inc. and Specialised Therapeutics Australia Announce Approval to Market ABRAXANE for Metastatic Breast Cancer in New Zealand 7/29/2010 8:04:43 AM
Abraxis BioScience, Inc.'s ABRAXANE(R) Approved for Marketing in Japan for Breast Cancer 7/23/2010 10:58:53 AM
Celgene (CELG) to Buy Abraxis BioScience, Inc. for $2.9 Billion 6/30/2010 6:36:12 AM
Abraxis BioScience, Inc. Release: American Society of Clinical Oncology Presentations Offer New Insights into Role of nab(R)-Chemotherapy Based Breast Cancer Chemotherapy Treatment 6/8/2010 9:41:32 AM
Abraxis BioScience, Inc. Release: Among the Toughest Cancers to Treat, New ABRAXANE(R) Data Demonstrates Potential in Patients with Advanced and Malignant Melanoma 6/8/2010 9:35:50 AM
12345678910...